BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 26008778)

  • 1. Malignancies arising in allograft kidneys, with a first reported translocation RCC post-transplantation: A case series.
    Saleeb R; Faragalla H; Yousef GM; Stewart R; Streutker CJ
    Pathol Res Pract; 2015 Aug; 211(8):584-7. PubMed ID: 26008778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities?
    Gigante M; Neuzillet Y; Patard JJ; Tillou X; Thuret R; Branchereau J; Timsit MO; Terrier N; Boutin JM; Sallusto F; Karam G; Barrou B; Chevallier D; Mazzola CR; Delaporte V; Doeffler A; Kleinclauss F; Badet L; ;
    BJU Int; 2012 Dec; 110(11 Pt B):E570-3. PubMed ID: 22726451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal cell carcinomas arising from the allograft and bilateral native kidneys.
    Nobushita T; Hara N; Nakagawa Y; Saito K; Nishiyama T; Takahashi K
    Int J Urol; 2008 Feb; 15(2):175-7. PubMed ID: 18269459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum.
    Rao Q; Williamson SR; Zhang S; Eble JN; Grignon DJ; Wang M; Zhou XJ; Huang W; Tan PH; Maclennan GT; Cheng L
    Am J Surg Pathol; 2013 Jun; 37(6):804-15. PubMed ID: 23598965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal cell carcinoma from a transplanted allograft: two case reports and a review of the literature.
    McHayleh W; Morcos JP; Wu T; Shapiro R; Yousem S; Appleman L; Friedland DM
    Clin Genitourin Cancer; 2008 Mar; 6(1):53-5. PubMed ID: 18501084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regular ultrasound examination of transplanted kidneys allows early diagnosis of renal cell carcinoma and conservative nephron sparing surgery.
    Lentini P; Granata A; Ciancio A; Gallieni M
    Arch Ital Urol Androl; 2011 Dec; 83(4):195-9. PubMed ID: 22670317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo concurrent papillary renal cell carcinoma and angiomyolipoma in a kidney allograft: evidence of donor origin.
    Rotman S; Déruaz C; Venetz JP; Chaubert P; Benhattar J; Meuwly JY; Jichlinski P; Guillou L; Moll S; Pascual M; Lemoine R
    Hum Pathol; 2006 Apr; 37(4):481-7. PubMed ID: 16564925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal cell carcinoma in kidney allografts: histologic types, including biphasic papillary carcinoma.
    Troxell ML; Higgins JP
    Hum Pathol; 2016 Nov; 57():28-36. PubMed ID: 27396934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of microscopic hematuria in the evaluation of urologic malignancy in renal transplant recipients.
    Kim DY; Abouljoud M; Parasuraman R
    Transplant Proc; 2010 Jun; 42(5):1641-2. PubMed ID: 20620491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xp11 translocation renal cell carcinoma morphologically mimicking clear cell-papillary renal cell carcinoma in an adult patient: report of a case expanding the morphologic spectrum of Xp11 translocation renal cell carcinomas.
    Parihar A; Tickoo SK; Kumar S; Arora VK
    Int J Surg Pathol; 2015 May; 23(3):234-7. PubMed ID: 25519951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service.
    Green WM; Yonescu R; Morsberger L; Morris K; Netto GJ; Epstein JI; Illei PB; Allaf M; Ladanyi M; Griffin CA; Argani P
    Am J Surg Pathol; 2013 Aug; 37(8):1150-63. PubMed ID: 23715164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Renal neoplasms and renal transplantation: current problems and future perspectives].
    Carrieri G; Netti GS; Perrone A; Stallone G; Selvaggi FP; Gesualdo L
    G Ital Nefrol; 2004; 21(6):547-53. PubMed ID: 15593022
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Moris D; Kakavia K; Argyrou C; Garmpis N; Bokos J; Vernadakis S; Diles K; Sotirchos G; Boletis J; Zavos G
    Anticancer Res; 2017 Feb; 37(2):773-779. PubMed ID: 28179329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromophobe renal cell carcinoma occurring in the renal allograft of a transplant recipient presenting with weight loss.
    Althaf MM; Al-Sunaid MS; Abdelsalam MS; Alkorbi LA; Al-Hussain TO; Dababo MA; Haq N
    Saudi J Kidney Dis Transpl; 2016 Jan; 27(1):139-43. PubMed ID: 26787581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum.
    Argani P; Olgac S; Tickoo SK; Goldfischer M; Moch H; Chan DY; Eble JN; Bonsib SM; Jimeno M; Lloreta J; Billis A; Hicks J; De Marzo AM; Reuter VE; Ladanyi M
    Am J Surg Pathol; 2007 Aug; 31(8):1149-60. PubMed ID: 17667536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of renal masses in transplant allografts at an Australian kidney-pancreas transplant unit.
    Su MZ; Campbell NA; Lau HM
    Transplantation; 2014 Mar; 97(6):654-9. PubMed ID: 24212503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary renal cell carcinoma in a transplanted kidney: genetic evidence of recipient origin.
    Boix R; Sanz C; Mora M; Quer A; Beyer K; Musulen E; González C; Bayona S; Saladié JM; Ariza A
    Transplantation; 2009 Apr; 87(7):1057-61. PubMed ID: 19352128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single center's approach to discriminating donor versus host origin of renal neoplasia in the allograft kidney.
    Robin AJ; Cohen EP; Chongkrairatanakul T; Saad E; Mackinnon AC
    Ann Diagn Pathol; 2016 Aug; 23():32-4. PubMed ID: 27402221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephron-sparing surgery of a low grade renal cell carcinoma in a renal allograft 12 years after transplantation.
    Mundel TM; Schaefer KL; Colombo-Benkmann M; Dietl KH; Diallo-Danebrock R; Senninger N
    Cancer Biol Ther; 2007 Nov; 6(11):1700-3. PubMed ID: 17986871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinomas.
    Mosquera JM; Dal Cin P; Mertz KD; Perner S; Davis IJ; Fisher DE; Rubin MA; Hirsch MS
    Diagn Mol Pathol; 2011 Sep; 20(3):129-37. PubMed ID: 21817901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.